RU2001118831A - Anti-inflammatory macrolides - Google Patents

Anti-inflammatory macrolides

Info

Publication number
RU2001118831A
RU2001118831A RU2001118831/04A RU2001118831A RU2001118831A RU 2001118831 A RU2001118831 A RU 2001118831A RU 2001118831/04 A RU2001118831/04 A RU 2001118831/04A RU 2001118831 A RU2001118831 A RU 2001118831A RU 2001118831 A RU2001118831 A RU 2001118831A
Authority
RU
Russia
Prior art keywords
groups
desdemethylamino
dehydroerythromycin
branched
linear
Prior art date
Application number
RU2001118831/04A
Other languages
Russian (ru)
Other versions
RU2243230C2 (en
Inventor
Франко Пеллачини
Даниела Ботта
Стефано Романьяно
Эрманно Мориджи
Лоренцо ПРАДЕЛЛА
Original Assignee
Дзамбон Гроуп С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI000061A external-priority patent/IT1306205B1/en
Application filed by Дзамбон Гроуп С.П.А. filed Critical Дзамбон Гроуп С.П.А.
Publication of RU2001118831A publication Critical patent/RU2001118831A/en
Application granted granted Critical
Publication of RU2243230C2 publication Critical patent/RU2243230C2/en

Links

Claims (6)

1. Соединение формулы1. The compound of the formula
Figure 00000001
Figure 00000001
в которой R представляет собой водород или метил;in which R represents hydrogen or methyl; R1 и R2 оба представляют собой водород они образуют химическую связь;R 1 and R 2 both represent hydrogen; they form a chemical bond; R3 представляет собой водород, линейную или разветвленную C15 алильную группу, бензильную группу, необязательно замещенную одним или более заместителем, выбранным из нитрогрупп, гидроксильных групп, карбоксильных групп, аминогрупп, линейных или разветвленных C1-C5 алкильных групп, C1-C4 алкоксикарбонильных групп, аминокарбонильных групп или цианогрупп, или цепи формулыR 3 represents hydrogen, a linear or branched C 1 -C 5 allyl group, a benzyl group optionally substituted with one or more substituents selected from nitro groups, hydroxyl groups, carboxyl groups, amino groups, linear or branched C 1 -C 5 alkyl groups, C 1 -C 4 alkoxycarbonyl groups, aminocarbonyl groups or cyano groups, or chains of the formula
Figure 00000002
Figure 00000002
где А представляет собой водород или фенильную группу, необязательно замещенную одним или двумя заместителями, выбранных из нитрогрупп, гидроксильных групп, карбоксильных групп, аминогрупп, линейных или разветвленных C1-C5 алкильных групп, C1-C4 алкоксикарбонильных групп, аминокарбонильных групп или цианогрупп, или 5- или 6-членных гетероциклов, насыщенных или ненасыщенных и содержащих от 1 до 3 гетероатомов, выбранных из азота, кислорода и серы, необязательно замещенных одним или двумя заместителями, выбранными из C1-C5 алкильных групп, фенильных групп, гидроксильных групп, оксо (=O)-групп, нитро-групп, C1-C4 алкоксикарбонильных групп, аминокарбонильных групп, моно- или ди-С14-алкиламинокарбонильных групп, С14-алкилкарбонильных групп;where A represents hydrogen or a phenyl group optionally substituted with one or two substituents selected from nitro groups, hydroxyl groups, carboxyl groups, amino groups, linear or branched C 1 -C 5 alkyl groups, C 1 -C 4 alkoxycarbonyl groups, aminocarbonyl groups, or cyano groups, or 5- or 6-membered heterocycles, saturated or unsaturated and containing from 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, optionally substituted with one or two substituents selected from C 1 -C 5 alkyl groups, phen alkyl groups, hydroxyl groups, oxo (= O) groups, nitro groups, C 1 -C 4 alkoxycarbonyl groups, aminocarbonyl groups, mono- or di-C 1 -C 4 -alkylaminocarbonyl groups, C 1 -C 4 -alkylcarbonyl groups; Х и Y, одинаковые или различные, представляют собой О, S, SO, SO2 или NR4, где R4 - водород, линейная или разветвленная C1-C5 алкильная группа, С15 алкоксикарбонильная группа, бензилоксикарбонильная группа;X and Y, the same or different, are O, S, SO, SO 2 or NR 4 , where R 4 is hydrogen, a linear or branched C 1 -C 5 alkyl group, a C 1 -C 5 alkoxycarbonyl group, a benzyloxycarbonyl group; r = 1 - 6;r is 1-6; m = 1 - 8;m is 1 to 8; n = 0 - 2;n is 0 to 2; и их фармацевтически приемлемые соли, причем исключены соединения: оксим 3’-дездиметиламино-3’,4’-дегидроэритромицина А и 9-O-метилоксим 3’-дездиметиламино-3’4’-дегидроэритромицина А.and their pharmaceutically acceptable salts, excluding compounds: oxime 3’-desdemethylamino-3 ’, 4’-dehydroerythromycin A and 9-O-methyloxy 3’-desdemethylamino-3’4’-dehydroerythromycin A.
2. Соединение по п.1, отличающееся тем, что R, R1 и R2 представляют собой водород.2. The compound according to claim 1, characterized in that R, R 1 and R 2 represent hydrogen. 3. Соединение по п.2, отличающееся тем, что R3 представляет собой цепь формулы3. The compound according to claim 2, characterized in that R 3 is a chain of the formula
Figure 00000003
Figure 00000003
в которой X, Y, А, r, m и n имеют значения, указанные в п.1.in which X, Y, A, r, m and n have the meanings indicated in claim 1.
4. Соединение по п.2, отличающееся тем, что R3 представляет собой цепь формулы4. The compound according to claim 2, characterized in that R 3 represents a chain of the formula
Figure 00000004
Figure 00000004
в которой r = 2;in which r = 2; m = 2 или 6;m is 2 or 6; n = 1,n = 1, Y представляет собой NR4;Y represents NR 4 ; Х представляет собой О или NR4;X represents O or NR 4 ; R4 представляет собой водород;R 4 represents hydrogen; А представляет собой фенил или тиазолил.A is phenyl or thiazolyl.
5. Соединения оксима 3’-дездиметиламино-3’,4’-дегидроэритромицина А и 9-O-метилоксима 3’-дездиметиламино-3’,4’-дегидроэритромицина А для применения в качестве противовоспалительных средств.5. Compounds of 3′-desdemethylamino-3 ’, 4’-dehydroerythromycin A oxime and 9-O-methyloxy 3’-desdemethylamino-3’, 4’-dehydroerythromycin A oxime for use as anti-inflammatory agents. 6. Фармацевтический состав, содержащий фармацевтически активное количество соединения по п.1 в смеси с фармацевтически приемлемым носителем.6. A pharmaceutical composition comprising a pharmaceutically active amount of a compound according to claim 1 in a mixture with a pharmaceutically acceptable carrier.
RU2001118831/04A 1999-01-15 2000-01-12 Macrolides and pharmaceutical composition based on thereof RU2243230C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000061A IT1306205B1 (en) 1999-01-15 1999-01-15 MACROLIDS WITH ANTI-INFLAMMATORY ACTIVITY.
ITMI99A000061 1999-01-15

Publications (2)

Publication Number Publication Date
RU2001118831A true RU2001118831A (en) 2003-06-10
RU2243230C2 RU2243230C2 (en) 2004-12-27

Family

ID=11381492

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001118831/04A RU2243230C2 (en) 1999-01-15 2000-01-12 Macrolides and pharmaceutical composition based on thereof

Country Status (19)

Country Link
US (1) US6455576B1 (en)
EP (1) EP1144427B1 (en)
JP (1) JP4568433B2 (en)
CN (1) CN1151165C (en)
AT (1) ATE308552T1 (en)
AU (1) AU769006B2 (en)
BR (1) BR0007514A (en)
CA (1) CA2368400C (en)
DE (1) DE60023647T2 (en)
ES (1) ES2251966T3 (en)
HU (1) HU229228B1 (en)
IL (2) IL144044A0 (en)
IT (1) IT1306205B1 (en)
MX (1) MXPA01007164A (en)
NO (1) NO318982B1 (en)
RU (1) RU2243230C2 (en)
SK (1) SK286772B6 (en)
WO (1) WO2000042055A2 (en)
ZA (1) ZA200105748B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
CN1665831A (en) 2002-07-08 2005-09-07 普利瓦研究院有限公司 Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory, antienoplastic and antiviral active molecules
BR0312584A (en) * 2002-07-08 2005-04-12 Pliva Istrazivacki Inst D O O New non-steroidal anti-inflammatory substances, compounds and methods for their use
EP1521764A2 (en) 2002-07-08 2005-04-13 PLIVA-ISTRAZIVACKI INSTITUT d.o.o. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ITMI20021726A1 (en) 2002-08-01 2004-02-02 Zambon Spa MACROLIDS WITH ANTI-INFLAMMATORY ACTIVITY.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
ITMI20022292A1 (en) 2002-10-29 2004-04-30 Zambon Spa 9A-AZALIDS WITH ANTI-INFLAMMATORY ACTIVITY.
US7410952B2 (en) 2003-04-17 2008-08-12 Sandoz Ag Derivatives of azithromycin
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
ITMI20040124A1 (en) * 2004-01-29 2004-04-29 Zambon Spa MACROLIDS WITH ANTI-INFLAMMATORY ACTIVITY
WO2006130128A2 (en) * 2004-02-18 2006-12-07 Chiron Corporation Methods of identifying anti-inflammatory macrolides
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP1812455A2 (en) * 2004-09-27 2007-08-01 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
BRPI0517024A (en) 2004-10-27 2008-03-25 Glaxosmithkline Zagreb conjugates with anti-inflammatory activity
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
RU2455309C2 (en) * 2010-07-20 2012-07-10 Открытое Акционерное Общество "Татхимфармпрепараты" Amorphous form of roxithromycin and synthesis method thereof
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
WO2021195126A1 (en) 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
IT1189285B (en) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale SALTS OF THE ERYTHROMYCIN ANTIBIOTIC AND ITS PROPIONIC ESTER WITH ACIDS WITH ADJUVANT THERAPEUTIC ACTIVITY
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
IT1276901B1 (en) * 1994-12-13 1997-11-03 Zambon Spa DERIVATIVES OF Erythromycin A 9-0-OXIN WITH ANTIBIOTIC ACTIVITY
KR19980701895A (en) * 1995-03-08 1998-06-25 이라우치지마 가즈다카 Immune-related disease treatment agent and method of searching for it

Similar Documents

Publication Publication Date Title
RU2001118831A (en) Anti-inflammatory macrolides
AR014448A1 (en) ALANINE COMPOUND, A PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUND AND PROCESS FOR THE PREPARATION OF THE COMPOUND
KR900018098A (en) Pyridone Carboxylic Acids and Antibacterials
PE20020483A1 (en) SELECTIVE CYCLIC PEPTIDES AS AGONISTS OF MELANOCORTIN 4 RECEPTORS
PE20070218A1 (en) AMINO-HYDANTOIN CYCLOALKYL COMPOUNDS AND USE OF THESE FOR THE MODULATION OF ß-SECRETASE
PE20000345A1 (en) ENZYME INHIBITORS
RU2012140961A (en) DERIVATIVE OF 1,3,4,8-TETRAHYDRO-2H-PYRIDO [1,2-a] PYRAZINE AND ITS APPLICATION AS AN HIV INTEGRASE INHIBITOR
EA200300412A1 (en) PHARMACEUTICAL ACTIVE DERIVATIVES OF SULPHONAMIDE, CONTAINING AS LYPOPHIL, SO AND IONIZABLE FRAGMENTS, AS AN INHIBITORS JUN-PROTEINKINAZ
PE20020589A1 (en) 5-SPIROPYRIMIDIN-2,4,6-TRIONA AS INHIBITORS OF METALOPROTEINASES
ATE212981T1 (en) 1-ACYL-4-ALIPHATIC AMINOPIPERIDINE COMPOUNDS
ATE63124T1 (en) PRODRUG COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND DELAYED RELEASE PREPARATIONS CONTAINING THEM.
RU2011154329A (en) BORIN ACID COMPOSITIONS
RU2005116248A (en) 9A-AZALIDES WITH ANTI-INFLAMMATORY ACTIVITY
KR920012082A (en) Novel amino and nitro containing tricyclic compounds useful as ACE inhibitors
RU2000122960A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ULCERS
RU2001126725A (en) HETEROCYCLIC COMPOUNDS, THEIR INTERMEDIATE PRODUCTS AND ELASTASE INHIBITORS
AR036176A1 (en) A PHENYL-ACETAMID-TIAZOL DERIVATIVE, A PROCEDURE FOR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PRODUCT OR KIT THAT UNDERSTANDS THEM, AND A METHOD THAT USES SUCH DERIVATIVE
KR910004568A (en) Substituted N- (quinolin-2-yl-methoxy) benzyl-sulfonylurea
CO5261527A1 (en) ETERES OF THE BENZOIC ACID OF OXAZOLIDINONES THAT HAVE A SUBSTITUENT HYDROXYACETILEPIPERAZINE
KR910000614A (en) New compounds
BG105123A (en) Tetrahydroquinaline derivatives as glycine antagonists
RU2003122785A (en) 9A-N- [N`- (Phenylsulfonyl) Carbamoyl) 9-Deoxy-9-Dihydro-9a-Aza-9a-Homoerythromycin A and 5-O-Desosaminyl-9-Dezoxamino-9-Di-Derivatives 9A-HOMOERITHRONOLIDE A
SE0203753D0 (en) New compounds
AR034557A1 (en) DERIVATIVES OF (2-AZABICLO [2.2.1] HEPT-7-IL) METHANOL AS AGE OF NICOTINIC RECEPTORS OF ACETILCOLINE
RU2383548C2 (en) Compounds as ccr-1 antagonists